Ledger.Open graph →
SEC Form D · filed March 11, 2020

Outlook Therapeutics, Inc

Offering
$8.0M
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Other
Location
CRANBURY, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Randy Thurman · CRANBURY, NJDirectorYezan Haddadin · Brooklyn, NYDirectorKurt J. Hilzinger · CRANBURY, NJDirectorLawrence A. Kenyon · CRANBURY, NJExec · DirectorFaisal G. Sukhtian · CRANBURY, NJDirectorJeff G. Evanson · Cranbury, NJExecTerry G. Dagnon · Cranbury, NJExecRandy Thurman · CRANBURY, NJDirectorYezan Haddadin · New York, NYDirectorKurt J. Hilzinger · CRANBURY, NJDirectorLawrence A. Kenyon · Monmouth Junction, NJExec · DirectorFaisal G. Sukhtian · CRANBURY, NJDirectorTerry G. Dagnon · Cranbury, NJExecJeff G. Evanson · Cranbury, NJExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗